A Long-term Safety Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes

Clinical trial NCT03861039 · COMPLETED

Trial details

NCT number: NCT03861039
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Type 2 Diabetes Mellitus

Start date: 2019-03-30
Primary completion: 2021-01-26
Enrollment: 443

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.